Tianyi Liu
Dalian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Virtual screening and MD simulation-guided discovery of CDK12-IN-3, a potent ALK inhibitor suppressing neuroblastoma growth in vitro and in vivo.
Journal: Frontiers in chemistry
Published: May 01, 2026
The MYC network: Hub of malignancy and blueprint for intervention.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: March 16, 2026
A pH‑responsive hairpin antisense oligonucleotide prodrug system based on the i‑motif for controlled release and enhanced In Vitro antitumor activity in MYCN-amplified cells.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: January 27, 2026
Identification of novel AURKA inhibitors against neuroblastoma using a virtual screening approach.
Journal: Bioorganic chemistry
Published: March 18, 2025
In-depth analysis of cystic fibrosis cases caused by CFTR gene variation and research on the prediction and simulation of the impact on protein function.
Journal: Frontiers in pediatrics
Published: February 11, 2025
Exploring FAM13A-N-Myc interactions to uncover potential targets in MYCN-amplified neuroblastoma: a study of protein interactions and molecular dynamics simulations.
Journal: BMC cancer
Published: November 14, 2024
In-depth analysis of OTC A208T case induced by OTC gene mutation and research on the prediction and simulation of the impact on protein function.
Journal: Frontiers in pediatrics
Published: June 18, 2024
Novel compound heterozygous mutations of the FBP1 gene in a patient with hypoglycemia and lactic acidosis: A case report.
Journal: Molecular genetics & genomic medicine
Published: September 25, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026